1. Home
  2. FTHM vs XCUR Comparison

FTHM vs XCUR Comparison

Compare FTHM & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.73

Market Cap

31.5M

Sector

Finance

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$4.83

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
XCUR
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
29.2M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
FTHM
XCUR
Price
$0.73
$4.83
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
69.5K
15.1K
Earning Date
03-30-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
27.21
N/A
EPS
N/A
N/A
Revenue
$335,184,000.00
$500,000.00
Revenue This Year
$30.07
N/A
Revenue Next Year
$14.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$3.10
52 Week High
$3.37
$14.54

Technical Indicators

Market Signals
Indicator
FTHM
XCUR
Relative Strength Index (RSI) 32.57 61.83
Support Level N/A $4.48
Resistance Level $1.49 $5.13
Average True Range (ATR) 0.06 0.28
MACD -0.01 0.13
Stochastic Oscillator 12.94 86.96

Price Performance

Historical Comparison
FTHM
XCUR

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: